• Amyloid Beta-peptide (25-35): Applied Neurotoxicity Models &

  2026-04-22

  Amyloid Beta-peptide (25-35) (Aβ25-35) is a gold-standard model for dissecting Alzheimer’s disease neurotoxicity and microglial polarization. Here, we translate the latest mechanistic insights and troubleshooting strategies into actionable workflows for robust, reproducible neurodegenerative disease research.

• A-769662: AMPK Activator Workflows for Metabolic Research

  2026-04-22

  A-769662 stands out as a potent, reversible AMPK activator, enabling precise control of energy metabolism and autophagy in both in vitro and in vivo settings. This article delivers actionable experimental workflows, troubleshooting guidance, and fresh insights from recent mechanistic breakthroughs—empowering metabolic syndrome and type 2 diabetes research with next-generation rigor.

• Chloroquine Diphosphate: Autophagy Control and Beyond in Can

  2026-04-21

  Explore how Chloroquine diphosphate, a leading autophagy modulator and TLR7/9 inhibitor, enables advanced cancer research beyond standard protocols. This article delivers novel mechanistic insights and practical assay guidance for optimal experimental design.

• Lanabecestat (AZD3293): Precision BACE1 Inhibition for Alzhe

  2026-04-21

  Lanabecestat (AZD3293) empowers Alzheimer’s disease research with potent, blood-brain barrier-penetrant BACE1 inhibition, enabling synaptic-sparing amyloid-beta modulation. This guide translates recent peer-reviewed breakthroughs and practical workflows into actionable, reproducible protocols for both in vitro and in vivo studies.

• Lanabecestat (AZD3293): Protocols for Synaptic-Safe BACE1 In

  2026-04-20

  Lanabecestat (AZD3293) empowers Alzheimer’s disease research with high-affinity, blood-brain barrier-penetrant BACE1 inhibition that preserves synaptic function at optimized dosages. This guide unpacks workflow-driven protocols, troubleshooting strategies, and a pivotal reference study to help researchers achieve reproducible, synaptic-sparing amyloid-beta reduction.

• Atropo-Enantioselective Suzuki Coupling Enables Chiral Biary

  2026-04-20

  This study describes a catalytic asymmetric Suzuki cross-coupling for the synthesis of axially chiral bridged biaryls, specifically targeting a structural analogue of (-)-rhazinilam with potent antimitotic properties. The work establishes a practical methodology for generating biologically relevant chiral biaryls, providing a foundation for future research in chiral ligand and natural product synthesis.

• IWP-L6: Precision Porcupine Inhibitor for Wnt Pathway Modula

  2026-04-19

  IWP-L6 stands out as a sub-nanomolar Porcupine inhibitor, enabling highly specific and reproducible Wnt pathway suppression in diverse experimental systems. This guide translates cutting-edge metabolic findings and validated protocols into actionable strategies for developmental, metabolic, and regenerative research.

• Tacrine-Based Hybrids: Advances in Multi-Target Strategies f

  2026-04-18

  This review examines the evolution of tacrine-based hybrids as multi-target agents for Alzheimer's disease, highlighting their design to address multiple pathological hallmarks beyond cholinesterase inhibition. The paper contextualizes tacrine's scientific legacy and explores how structural modifications may overcome prior limitations, such as hepatotoxicity, offering new avenues for neurodegenerative disease research.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Research Pre

  2026-04-17

  Kanamycin Sulfate is a high-purity, water-soluble antibiotic widely used in microbiology and antibiotic resistance research. Its mechanism involves selective inhibition of bacterial protein synthesis by targeting the 30S ribosomal subunit. APExBIO's Kanamycin Sulfate (SKU A2516) offers validated purity and performance, supporting reproducible experimental outcomes.

• Cy5-UTP for RNA Labeling: Protocols, Applications & Troubles

  2026-04-16

  Cy5-UTP (Cyanine 5-UTP) enables robust, direct fluorescent RNA probe synthesis for advanced applications like FISH and dual-color arrays. This guide details stepwise workflows, expert troubleshooting, and data-driven enhancements to maximize labeling sensitivity and reproducibility.

• Ceftazidime: Third-Generation Cephalosporin in Gram-Negative

  2026-04-15

  Ceftazidime enables robust, reproducible workflows for Gram-negative bacterial infection research, with proven β-lactamase resistance that enhances assay reliability. Learn how to optimize its use for experimental precision and troubleshoot common pitfalls, leveraging new insights from resistance transmission dynamics.

• Starvation-Induced ER-Ca2+-Calpain Axis Drives PCD in Bombyx

  2026-04-14

  This study dissects how starvation triggers a regulated switch from autophagy to apoptosis in the Bombyx mori fat body, mediated by ER Ca2+ signaling and calpain activation. The work clarifies the molecular logic underlying programmed cell death transitions under nutritional stress and demonstrates the pivotal role of IP3R-mediated calcium mobilization.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Use &

  2026-04-13

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is formulated to prevent unwanted proteolysis during protein extraction and sample handling, particularly when divalent cations must be preserved for downstream assays. It should be used in workflows where EDTA would interfere, such as phosphorylation analysis or enzyme assays, but is not suitable for applications that require metalloprotease inhibition via chelation.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-04-13

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with diverse stromal cell subpopulations, enabling a physiologically relevant platform for drug screening and resistance studies. The model offers improved mimicry of tumor heterogeneity, supporting more predictive and personalized preclinical research.

• Sunitinib as a Multi-Targeted RTK Inhibitor: Protocols & Tro

  2026-04-12

  Leverage Sunitinib’s multi-targeted receptor tyrosine kinase inhibition to dissect angiogenesis, apoptosis, and cell cycle arrest in advanced cancer models. This guide translates cutting-edge glioma research into actionable workflows, offering experimental enhancements and troubleshooting strategies for reliable, reproducible results with APExBIO’s Sunitinib.

16136 records 1/1076 page Next 12345 下5页 Last page